Generali Asset Management SPA SGR Takes Position in Cameco Co. (NYSE:CCJ)

Generali Asset Management SPA SGR acquired a new stake in Cameco Co. (NYSE:CCJ) (TSE:CCO) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 3,244 shares of the basic materials company’s stock, valued at approximately $167,000.

Several other large investors have also made changes to their positions in CCJ. AGF Management Ltd. lifted its position in shares of Cameco by 54.2% in the fourth quarter. AGF Management Ltd. now owns 3,393,233 shares of the basic materials company’s stock worth $174,433,000 after buying an additional 1,193,266 shares in the last quarter. Bridgewater Associates LP lifted its position in shares of Cameco by 19.9% in the third quarter. Bridgewater Associates LP now owns 2,478,488 shares of the basic materials company’s stock worth $118,386,000 after buying an additional 410,711 shares in the last quarter. Progeny 3 Inc. lifted its position in shares of Cameco by 7.5% in the third quarter. Progeny 3 Inc. now owns 2,268,132 shares of the basic materials company’s stock worth $108,326,000 after buying an additional 159,200 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of Cameco by 9.4% in the third quarter. The Manufacturers Life Insurance Company now owns 2,175,038 shares of the basic materials company’s stock worth $103,968,000 after buying an additional 187,512 shares in the last quarter. Finally, Amundi lifted its position in shares of Cameco by 1.5% in the fourth quarter. Amundi now owns 2,156,893 shares of the basic materials company’s stock worth $110,821,000 after buying an additional 32,825 shares in the last quarter. 70.21% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on CCJ shares. Stifel Canada upgraded Cameco to a “strong-buy” rating in a research report on Wednesday, March 12th. StockNews.com upgraded Cameco from a “sell” rating to a “hold” rating in a research report on Wednesday. Royal Bank of Canada reissued an “outperform” rating and set a $90.00 price objective on shares of Cameco in a research note on Tuesday, March 4th. Glj Research boosted their price objective on Cameco from $62.76 to $75.68 and gave the stock a “buy” rating in a research note on Wednesday, March 12th. Finally, Stifel Nicolaus assumed coverage on Cameco in a research note on Wednesday, March 12th. They set a “buy” rating on the stock. One research analyst has rated the stock with a hold rating, seven have issued a buy rating and three have given a strong buy rating to the stock. According to data from MarketBeat.com, Cameco currently has a consensus rating of “Buy” and a consensus target price of $73.64.

Cameco Trading Down 0.5 %

CCJ opened at $44.62 on Friday. The stock has a market cap of $19.42 billion, a price-to-earnings ratio of 159.34 and a beta of 1.04. The stock’s 50 day moving average price is $47.03 and its 200-day moving average price is $50.01. Cameco Co. has a one year low of $35.43 and a one year high of $62.55. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.26 and a current ratio of 2.88.

Cameco (NYSE:CCJ) (TSE:CCO) last released its earnings results on Thursday, February 20th. The basic materials company reported $0.26 EPS for the quarter, meeting analysts’ consensus estimates of $0.26. The firm had revenue of $845.54 million for the quarter, compared to analysts’ expectations of $1.09 billion. Cameco had a return on equity of 4.34% and a net margin of 5.39%. On average, equities analysts forecast that Cameco Co. will post 1.27 EPS for the current year.

About Cameco

Cameco Corporation provides uranium for the generation of electricity. It operates through Uranium, Fuel Services, Westinghouse segments. The Uranium segment is involved in the exploration for, mining, and milling, purchase, and sale of uranium concentrate. The Fuel Services segment engages in the refining, conversion, and fabrication of uranium concentrate, as well as the purchase and sale of conversion services.